Search

everythinglearnresearchcommunity

for

Search:↓

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Dutasteride and finasteride affect different cell types differently.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

Muscarinic acetylcholine receptors help regulate and promote hair growth.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Polydopamine and quercetin together can speed up hair regrowth.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

PGD2 stops hair growth and is higher in bald men with AGA.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

TRPV4 helps sense pressure in mouse skin.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.